Group Ocampo, University of Lausanne ^{Research Labs}

Their group conducts research in the areas of epigenetics, stem cells, aging and mitochondrial diseases with the goal of elucidating disease mechanisms and develop novel therapeutic approaches to improve the quality of life of patients. Their goal in the lab is to understand the role of epigenetic dysregulation as driver of aging and disease and develop novel strategies based on epigenetic reprogramming to prevent or revert the manifestation of aging and disease phenotypes. Also to use induced pluripotent stem cells derived from mitochondrial disease patients to develop novel therapeutic approaches based on the induction of heteroplasmy shift for the treatment of mitochondrial disease patients.